Get started
Author

Hidenori Maruyama

Observed names: H. Maruyama, HIDENORI MARUYAMA
ORCID: 0000-0002-1356-8100
Observed ORCID: 0000-0002-1356-8100
OpenAlex ID: A5018499375
Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro
2005 · Hajime Yoshifuji, Hisanori Umehara, et al. · International Immunology · 28
Effects of intrathymic injection of organ‐specific autoantigens, parietal cells, at the neonatal stage on autoreactive effector and suppressor T cell precursors
1993 · Kyoko Murakami, Hidenori Maruyama, et al. · European Journal of Immunology · 23
Germ-Free Condition and the Susceptibility of Balb/C Mice to Post-Thymectomy Autoimmune Gastritis
1992 · Kyoko Murakami, Hidenori Maruyama, et al. · Autoimmunity · 19
Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials
2020 · Kazuko Hasegawa, Kenji Kochi, et al. · Journal of Alzheimer s Disease · 11
Murine Endothelial Cell Line Cells, F‐2: Interaction with Leukocytes and Cytokines Production
1993 · Hidenori Maruyama, Ken‐ichi Toda, et al. · Microbiology and Immunology · 9
PDF
Effect of Lurasidone on Life Engagement in Schizophrenia: Post-Hoc Analysis of the JEWEL Study
2024 · Hidenori Maruyama, Fumiya Sano, et al. · Neuropsychiatric Disease and Treatment · 8
PDF
Zonisamide improves wearing off in Parkinson's disease without exacerbating dyskinesia: Post hoc analysis of phase 2 and phase 3 clinical trials
2021 · Yoshio Tsuboi, Masatoshi Nakamura, et al. · Journal of the Neurological Sciences · 8
PDF
Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study
2024 · Itaru Miura, Fumiya Sano, et al. · The Journal of Clinical Psychiatry · 5
PDF
Lurasidone for bipolar I depression with comorbid anxiety symptoms: Post-hoc-analysis of randomized, placebo-controlled studies
2025 · Takeshi Inoue, Takahiro Masuda, et al. · Journal of Affective Disorders · 4
Associations Between Cognitive Impairment, Depressive Symptoms, and Work Productivity Loss in Patients With Bipolar Disorder: A Cross‐Sectional Analysis
2025 · Yoshikazu Takaesu, Ayano Shiroma, et al. · Neuropsychopharmacology Reports · 3
PDF
Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study
2022 · Itaru Miura, Kei Watabe, et al. · Neuropsychiatric Disease and Treatment · 3
PDF
Zonisamide for Treating Parkinson’s Disease
2020 · Ritsuko Hanajima, Hidenori Maruyama, et al. · Springer eBooks · 3
Interspecies‐specific Ovarian Autoantigens Involved in Neonatal Thymectomy‐induced Murine Autoimmune Oophoritis
1993 · ZHU XUN, HIDENORI MARUYAMA, et al. · American Journal of Reproductive Immunology · 3
Zonisamide improves axial symptoms in dementia with Lewy bodies with parkinsonism: Post hoc analysis of clinical trials
2021 · Yoshio Tsuboi, Kenji Kochi, et al. · eNeurologicalSci · 2
Zonisamide for Treating Parkinson’s Disease
2022 · Ritsuko Hanajima, Hidenori Maruyama, et al. · Springer eBooks · 1
Effects of switching from dopamine agonists to zonisamide on psychiatric and motor symptoms in patients with Parkinson’s disease
2021 · Takashi Abe, Hidenori Maruyama · Rinsho Shinkeigaku · 1
PDF
Efficacy of lurasidone on anxiety symptoms in patients with schizophrenia: A pooled post hoc analysis of five randomized, placebo‐controlled trials
2025 · Takahiro Nemoto, Miyuki Okumura, et al. · Psychiatry and Clinical Neurosciences Reports
The Efficacy of Lurasidone in Bipolar I Depression: Subgroup Analysis by Severity of Anxiety Symptoms
2025 · *Takeshi Inoue, Takahiro Masuda, et al. · The International Journal of Neuropsychopharmacology
PDF
Zonisamide improves Parkinsonism in Dementia with Lewy Bodies (DLB): A randomized double-blind placebo-controlled Phase 3 study
2018 · K. Hasegawa, M. Murata, et al. · Parkinsonism & Related Disorders
Works count: 19
Citation count: 131
H-index: 7
I10-index: 4
Year
Topic
Type